MedTrace Logo

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

NCT02554552 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2016-11-17

No results posted yet for this study

Summary

This is a multicenter, randomized, double-blinded, parallel, placebo-controlled, phase I/IIa clinical trial of YY1201 for treatment of osteoarthritis of the knee.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

YY1201 2ml

YY1201 2ml

DRUG

Placebo 2ml

phosphate buffered saline 2ml

DRUG

YY1201 3ml

YY1201 2ml

DRUG

Placebo 3ml

phosphate buffered saline 3ml

Sponsors & Collaborators

  • Yooyoung Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chul-Won Ha, M.D. · Samsung Medical Center, Department of Internal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02554552 on ClinicalTrials.gov